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ANALYSIS OF A MODEL FOR THE DYNAMICS OF PRIONS II
HANS ENGLER, JAN PRU¨SS, AND GLENN F. WEBB
Abstract
A new mathematical model for the dynamics of prion proliferation involving an ordinary differential equation
coupled with a partial integro-differential equation is analyzed, continuing the work in [9]. We show the well-
posedness of this problem in its natural phase space Z+ := R+ × L
+
1
((x0,∞); xdx), i.e. there is a unique global
semiflow on Z+ associated to the problem.
A theorem of threshold type is derived for this model which is typical for mathematical epidemics. If a certain
combination of kinetic parameters is below or at the threshold, there is a unique steady state, the disease-free
equilibrium, which is globally asymptotically stable in Z+; above the threshold it is unstable, and there is another
unique steady state, the disease equilibrium, which inherits that property.
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1. Introduction and Main Results
In this paper we continue our analysis, begun in [9], of a recent model describing the proliferation
of prions. This model has been introduced in Greer, Pujo-Menjouet and Webb [4], based on the
works of Masel, Jansen and Nowak [6], Nowak, Krakauer, Klug and May [7] and others. For
comprehensive explanations and discussions of the model and the relevant biochemical literature
we refer to [4]. Here we only give a very short description of the model.
Prions are proteins that are believed to be responsible for certain diseases like BSE and the
Creutzfeld-Jacob disease. There are two basic forms of prions of interest here, the Prion Protein
Cellular PrPC and the Prion Protein Scrapie PrPSc. The single molecule proteins PrPC , also
called monomers in the sequel, are protease resistent proteins which have a cell protective function
and are produced by the body, regularly. On the other hand, the infectious prion PrPSc is a
string-like polymer formed of monomeric PrPC . Above a critical chain length x0 > 0 the polymers
are more stable than the PrPC , and they can grow to chains containing thousands of monomers.
PrPSc has the ability to replicate by splitting, we assume binary splitting here.
So there are three main processes which govern the dynamics of prions in this model.
• growth in length by polymerization with rate τ > 0;
• binary splitting with rate β(x) > 0, a polymer of length x > 0 splits into one of length
0 < y < x and one of length x− y with probability κ(y, x);
• natural degradation with rate γ > 0 for the monomers and with rate µ(x) for the polymers
with length x.
The model proposed in [7] further assumes that polymers of length 0 < x ≤ x0 immediately
decompose completely into monomers. This reflects the assumption that PrPSc polymers are
unbranched and form a simple α-helix with x0 monomer units per turn. An α-helix of length less
than x0 is incomplete and thus is much less stable. Denoting the numbers of monomers at time t
by V (t) and the density of polymers by u(t, x), we obtain the following model equations.
∂tV (t) = λ− γV (t)− τV (t)
∫ ∞
x0
u(t, x)dx+ 2
∫ x0
0
x
∫ ∞
x0
β(y)κ(x, y)u(t, y)dydx
∂tu(t, x) + τV (t)∂xu(t, x) + (µ(x) + β(x))u(t, x) = 2
∫ ∞
x
β(y)κ(x, y)u(t, y)dy(1.1)
V (0) = V0 ≥ 0, u(t, x0) = 0, u(0, x) = u0(x),
1
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where t ≥ 0 and x0 ≤ x <∞. Here λ > 0 is a constant background source of monomers. Observe
that the splitting function κ(y, x) should satisfy the following properties.
κ(y, x) ≥ 0, κ(y, x) = κ(x− y, x),
∫ x
0
κ(y, x)dy = 1,
for all x ≥ x0, y ≥ 0, and κ(y, x) = 0 if y > x or x ≤ x0. Note that these conditions imply
2
∫ x
0
yκ(y, x)dy = x, x > 0.
In fact,
2
∫ x
0
yκ(y, x)dy =
∫ x
0
yκ(y, x)dy +
∫ x
0
yκ(x− y, x)dy
=
∫ x
0
yκ(y, x)dy +
∫ x
0
(x− y)κ(y, x)dy = x
∫ x
0
κ(y, x)dy = x.
This implies that mass does not change via the splitting process, and by a simple computation
we obtain the following relation for the total number of monomers in the system.
d
dt
[V (t) +
∫ ∞
x0
xu(t, x)dx] = λ− γV (t)−
∫ ∞
x0
xµ(x)u(t, x)dx, t ≥ 0.
In [7] it is further assumed that splitting is equi-distributed (polymer chains are equally likely to
split at all locations), and that the rate of splitting is proportional to length. This reflects again the
hypothesis that polymers form α-helices and are not folded in more complicated configurations,
which would make certain segments of the chain less likely to split than others. Therefore, we
make the further assumptions
κ(y, x) = 1/x if x > x0 and 0 < y < x, κ(y, x) = 0 elsewhere ,
β(x) = βx is linear, and µ(x) ≡ µ constant. Then the model contains only 6 parameters, and
can even be reduced to a system of 3 ordinary differential equations. In fact, introduce the new
functions
U(t) =
∫ ∞
x0
u(t, y)dy and P (t) =
∫ ∞
x0
yu(t, y)dy,
representing the total number of polymers, and the total number of monomers in polymers at time
t, respectively. Integrating the equation for u(t, x) over [x0,∞) we get
d
dt
U(t) = −τV (t)u(t, x)|∞x0 − µU(t)− βP (t) + 2β
∫ ∞
x0
∫ ∞
x
u(t, y)dydx
= −µU(t)− βP (t) + 2β
∫ ∞
x0
u(t, y)(y − x0)dy
= −µU(t)− βP (t) + 2βP (t)− 2βx0U(t),
hence
U˙(t) = −(µ+ 2βx0)U(t) + βP (t).
Multiplying the equation for u(t, x) by x, integration yields
d
dt
P (t) = −τV (t)(xu(t, x)|∞x0 −
∫ ∞
x0
u(t, y)dy)
−µP (t)− β
∫ ∞
x0
u(t, x)x2dx+ 2β
∫ ∞
x0
x
∫ ∞
x
u(t, y)dydx
= τV (t)U(t)− µP (t)− β
∫ ∞
x0
u(t, x)x2dx+ β
∫ ∞
x0
u(t, y)(y2 − x20)dy
= τV (t)U(t)− µP (t)− βx20U(t),
hence
P˙ (t) = τU(t)V (t)− µP (t)− βx20U(t).
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Thus we obtain the following closed model involving only ordinary differential equations.
U˙ = βP − µU − 2βx0U
V˙ = λ− γV − τUV + βx20U(1.2)
P˙ = τUV − µP − βx20U
with initial conditions
U(0) = U0 ≥ 0, V (0) = V0 ≥ 0, P (0) = P0 ≥ x0U0.
This way the partial differential equation for the density u(t, x) decouples from the ordinary dif-
ferential equations. Once the solutions of (1.2) are known, one has to solve only a linear partial
integro-differential eqution to obtain u(t, x). The system (1.2) is identical to the ”basic virus
dynamics model” that is discussed at length in [8].
Concerning the ode-system (1.2) we have the following result from Pru¨ss, Pujo-Menjouet, Webb
and Zacher [9].
Theorem 1.1. Suppose x0, β, γ, λ, µ, τ > 0 are given constants. Then the system (1.2) induces a
global semiflow on the set K = {(U, V, P ) ∈ R3 : U, V, P−x0U ≥ 0}. There is precisely one disease
free equilibrium (0, λ/γ, 0) which is globally exponentially stable if and only if µ+ x0β >
√
λβτ/γ,
and asymptotically stable in case of equality. On the other hand, if µ + x0β <
√
λβτ/γ there is
the unique disease equilibrium(λβτ − γ(µ+ βx0)2
µτ(µ + 2βx0)
,
(µ+ βx0))
2
βτ
,
λβτ − γ(µ+ βx0)2
βµτ
)
which is globally exponentially stable in K \ [{0} × R+ × {0}].
It is the purpose of this paper to study the full system (1.1) under the assumptions of equi-
distributed splitting, linear splitting rate, and constant rates of degradation.
Since V (t)+
∫∞
x0
xu(t, x)dx is the total number of monomers in the system, which should be finite
at any time, it seems reasonable to study (1.1) in the standard cone Z+ := R+×L+1 ((x0,∞);xdx)
of the Banach space Z := R× L1((x0,∞);xdx). The following theorem summarizes our results.
Theorem 1.2. Assume equi-distributed splitting with linear splitting rate β(x) = βx and constant
degradation rates γ and µ(x) ≡ µ. Suppose λ, τ, β, γ, µ, x0 > 0. Then (1.1) generates a global
semiflow in the natural phase space Z+. Furthermore,
(i) if λβτ/γ ≤ (µ+βx0)2, then the disease-free equilibrium z¯ = (λ/γ, 0) is globally asymptotically
stable in Z+, and even exponentially in the case of strict inequality;
(ii) if λβτ/γ > (µ + βx0)
2, then there is a unique disease equilibrium z∗ = (V∗, u∗) which is
globally asymptotically stable in Z+ \ (R+ × {0}). It is given by
V∗ =
(µ+ βx0)
2
βτ
, u∗(x) =
2β
µτ
λβτ − γ(µ+ βx0)2
(µ+ βx0)(µ+ 2βx0)
Φ
(β(x − x0)
µ+ βx0
)
,
where Φ(r) = (r + r2/2) exp(−(r + r2/2)).
The remaining part of this paper deals with the proof of this result. Recall that the function
ω(t) := τV (t) can be considered as known, by Theorem 1.1, and ω(t)→ ω∞ exponentially, where
either ω∞ = λ/γ in the disease-free or ω∞ = (µ + βx0)
2/β in the disease case. Hence we have to
solve a linear nonautonomous partial integro-differential equation of first order. For this we shall
use standard techniques from the theory of C0-semigroups and we refer to the monograph Arendt,
Batty, Hieber and Neubrander [2] as a general reference for the results employed below.
We proceed in four steps. First we study the autonomous case where ω ≡ ω∞. In Section 2
we show that there is a unique C0-semigroup T (t) = e
−Lt associated with the pde-part of (1.1)
in X = L1((x0,∞);xdx), which is positive and contractive, and even exponentially stable in the
disease-free case. The resolvent of L is shown to be compact in Section 3, hence L has only point
spectrum in the closed right half-plane. In the disease case, we further show that 0 is the only
eigenvalue of L on the imaginary axis, it is simple and so the ergodic projection P onto the kernel
N(L) of L along the range R(L) of L exists and is rank one. We compute an element e ∈ N(L)
which is positive. A result of Arendt, Batty, Lubich and Phong [2] then shows that T (t) is strongly
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ergodic, i.e. limt→∞ T (t) = P strongly in X . Wellposedness of the nonautonomous problem is
proved in Section 4 by means of monotone convergence, it is shown that the evolution operator
exists and is bounded. Moreover, bounds for ∂xu(t, ·) in X are derived. Finally, in Section 5 we
put together these results to prove Theorem 1.2.
While we assume throughout that β(x) = βx, µ(x) = µ (constant), and yκ(x, y) = 1 for x <
y, y > x0, κ(x, y) = 0 elsewhere, our methods extend to versions of (1.1) where these assumptions
do not hold. We do not carry out these generalizations since it is not clear which would be
biologically reasonable. On the other hand, the equation discussed in this paper
∂tu(t, x) = −τV (t)∂xu(t, x)− (µ+ βx)u(t, x) + 2β
∫ ∞
x
u(t, y)dy
for x > x0, t > 0, with initial and boundary data as in (1.1), can be solved with an integral
transformation followed by the method of characteristics. Namely, define
v(t, x) =
∫ ∞
x
∫ ∞
y
u(t, ξ) dξ dy =
∫ ∞
x
(ξ − x)u(t, ξ) dξ, ∂2xv(t, x) = u(t, x) .
Then a computation shows that v solves the first order partial differential equation without integral
term
∂tv(t, x) = −τV (t)∂xv(t, x)− (µ+ βx)v(t, x)
for x > x0, t > 0, with initial data v(0, x) obtained by integrating u0 twice and boundary data
v(t, x0) = P (t)− x0U(t). The equation for v may be solved by the method of characteristics, and
u is recovered from ∂2xv(t, x) = u(t, x). The solution depends on the initial data in the region
{(x, t) |x > x0 + τ
∫ t
0
V (s)ds } and on the boundary data in the complement of this region. Since
V (t) always has a positive limit, it is evident that the contribution from the initial data is swept
out towards large x-values and decays exponentially, in fact, at a rate like e−εt
2
for some ε > 0. If
the disease-free state is stable, then (P (t), U(t))→ (0, 0) as t→∞, which implies that the solution
u converges to zero also in the region where it depends on the boundary data. In the case of a
positive disease equilibrium, P (t) − x0U(t) has a positive limit as t → ∞, which determine the
limiting equilibrium distribution u∗ given in Theorem 1.2. This method breaks down if β(·), µ(·),
or κ(·, ·) have more complicated forms, as the reader will readily confirm.
2. The Linear Automomous Problem
2.1. Functional Analytic Setting. We consider the problem
∂tu(t, x) + ω∂xu(t, x) + (µ+ βx)u(t, x) = 2β
∫ ∞
x
u(t, y)dy,(2.1)
u(0, x) = u0(x), u(t, x0) = 0, t > 0, x > x0.
Set w(t, x) = u(t, x+ x0), x ≥ 0. Then this problem becomes the following one on R+.
∂tw(t, x) + ω∂xw(t, x) + (µ0 + βx)w(t, x) = 2β
∫ ∞
x
w(t, y)dy,(2.2)
w(0, x) = g(x) := u0(x + x0), w(t, 0) = 0, t > 0, x > 0.
Here we have set µ0 = µ+ βx0. ω plays the role of τV at ∞, i.e.
ω = τV (∞) = λτ/γ
in the disease-free case or
ω = τV (∞) = (µ+ βx0)2/β = µ20/β
in the disease case.
We want to study (2.2) in the basic space X = L1(R+; (a+x)dx), where we choose as the norm
||w|| = a|w|1 + |xw|1,
with a > 0 to be determined later. We define two linear operators in X by means of
Au(x) = ωu′(x) + (µ0 + βx)u(x), x ∈ R+,
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with domain
D(A) = {u ∈W 11 (R+) ∩X : x2u ∈ L1(R+), xu′(x) ∈ L1(R+), u(0) = 0},
and
Bu(x) = 2β
∫ ∞
x
u(y)dy, D(B) = D(A).
Both operators are well-defined and linear, B will be considered as a perturbation of A.
2.2. m-Accretivity of A. We have∫ ∞
0
Au sgnudx = ω
∫ ∞
0
|u|′dx+ µ0|u|1 + β|xu|1
= µ0|u|1 + β|xu|1,
and ∫ ∞
0
Au sgnuxdx = ω
∫ ∞
0
|u|′xdx+ µ0|xu|1 + β|x2u|1
= −ω|u|1 + µ0|xu|1 + β|x2u|1.
Employing the bracket in L1 this implies
[Au, u]+ ≥ (aµ0 − ω)|u|1 + (aβ + µ0)|xu|1 ≥ η||u||,
for some η > 0 provided µ0 > ω/a. Hence for such a, A is strictly accretive, in particular closable.
Next we compute the resolvent of A. The equation (λ + A)u = f is equivalent to solving the
ode
(2.3) λu(x) + ωu′(x) + (µ0 + βx)u(x) = f(x), x > 0,
with initial condition u(0) = 0. Therefore we obtain
u = (λ+A)−1f(x) =
1
ω
∫ x
0
exp−[(λ+ µ0)(x− y)/ω + β(x2 − y2)/2ω]f(y)dy.
If f ∈ L1(R+) then on easily obtains the estimate
|u|1 ≤ |f |1/(λ+ µ0).
If also xf ∈ L1(R+) then
|x2u(x)| ≤ 1
ω
∫ x
0
e−(λ+µ0)(x−y)/ω(x2 − y2)e−β(x2−y2)/2ω)|f(y)|dy
+
1
ω
∫ x
0
ye−β(x−y)2y/2ωy|f(y)|dy,
hence
|x2u|1 ≤ 1
ω
ω
λ+ µ0
2ω
βe
|f |1 + 1
ω
ω
β2
|xf |1.
This shows that x2u ∈ L1(R+), hence xu ∈ L1(R+), and then by equation (2.3) also u′ ∈ L1(R+)
as well as xu′ ∈ L1(R+), i.e. u ∈ D(A). This shows that A is m-accretive.
As a consequence we note that −A generates a C0-semigroup in X which is also positive and
strictly contractive, hence exponentially stable.
2.3. Accretivity of A− B. We have
|
∫ ∞
x
u(x)dx|1 ≤ |xu|1, |x
∫ ∞
x
u(x)dx|1 ≤ 1
2
|x2u|1,
and therefore ∫ ∞
0
(Au−Bu) sgn(u)dx ≥ µ0|u|1 + β|xu|1 − 2β|xu|1,
as well as ∫ ∞
0
(Au −Bu) sgn(u)xdx ≥ −ω|u|1 + µ0|xu|1.
6 HANS ENGLER, JAN PRU¨SS, AND GLENN F. WEBB
This yields
[(A−B)u, u]+ ≥ (µ0a− ω)|u|1 + (µ0 − βa)|xu|1 ≥ 0,
for all u ∈ D(A), provided µ0a ≥ ω and µ0 ≥ βa. Such a choice of a > 0 is possible if and only if
the condition ω/µ0 ≤ µ0/β is met, i.e. if and only if
ω ≤ µ20/β
holds true. Now in the disease-free case we have ω = λτ/γ, while in the disease case ω = µ20/β;
then a = µ0/β. Thus A − B will be strictly accretive in the disease-free case while it will be
accretive only in the disease case. In the first case, the decay rate can easily be estimated not to
be smaller than µ0 −
√
λβτ/γ.
2.4. Density of the Range of A − B. Let f ∈ L1(R+; (a + x)dx) be given and assume f ≥ 0.
Set u1 = (1 +A)
−1f and define the sequence un inductively by means of
un+1 = u1 + (1 +A)
−1Bun.
Then u1 ≥ 0, and u2 − u1 = (1 +A)−1Bu1 ≥ 0, hence by induction un+1 ≥ un pointwise, since B
is positive. This shows that the sequence of functions un is nonnegative and increasing pointwise.
Moreover,
ωu′n + (1 + µ0 + βx)un = f + 2β
∫ ∞
x
un−1(y)dy ≤ f + 2β
∫ ∞
x
un(y)dy,
which implies
(1 + µ0)|un|1 + β|xun|1 ≤ |f |1 + 2β|xun|1,
and
−ω|un|1 + (1 + µ0)|xun|1 + β2|x2un|1 ≤ |xf |1 + β|x2un|1.
Choosing a as above this yields an a priori bound for the sequence (un)
||un|| = a|un|1 + |xun| ≤ C||f ||,
and therefore we may conclude by the monotone convergence theorem un → u∞ as n → ∞. If
in addition x2f ∈ L1(R+) then we obtain in a similar way boundedness of x2un in X . This
implies (1 + A − B)un = f + B(un−1 − un) → f in X as n → ∞, hence u∞ ∈ D(A−B) and
u∞ = (1 +A−B)−1f . Since L1 = L+1 − L+1 we may conclude R(1 +A−B) = X , i.e. the closure
of A−B is m-accretive.
Remark 2.1. The above proof shows that the resolvent of A−B is positive, hence the semigroup
generated by this operator will be as as well.
2.5. Irreducibility. Suppose f ∈ X is nonnegative and u solves
ωu′ + (λ + µ0 + βx)u = f + 2β
∫ ∞
x
u(y)dy, x ≥ 0,
with initial value u(0) = 0. If f 6≡ 0 then let x1 := inf supp f . We have
u(x) =
1
ω
∫ x
0
exp−[(λ+ µ0)(x − y)/ω + β(x2 − y2)/2ω][f(y) +Bu(y)]dy.
Since we already know u(x) ≥ 0, this formula implies u(x) > 0 for all x > x1. But then∫∞
x
u(y)dy > 0 for all x ≥ 0, and so so u(x) > 0 for all x > 0. This proves the irreducibility
of the semigroup generated by A−B.
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2.6. A − B is not Closed. Unfortunately, the sum A − B is not closed. We show this by the
following example.
Example 2.2. Set u = χ/x3 where χ denotes a cut-off function which is 0 on [0, 1] and 1 on
[2,∞). Then u, u′u, xu ∈ L1(R+), but x2u 6∈ L1(R+), and u(0) = 0. On the other hand,
f(x) := ωu′(x) + (λ+ µ0 + βx)u(x) − 2β
∫ ∞
x
u(y)dy
= ωχ′/x3 − 3ωχ/x4 + (λ+ µ0)χ/x3 + βχ/x2 − 2β
∫ ∞
x
χ(y)dy/y3
Since
χ(x)/x2 − 2
∫ ∞
x
χ(y)dy/y3 = χ(x)/x2 + χ(y)/y2|∞x −
∫ ∞
x
χ′(y)dy/y2
= −
∫ ∞
x
χ′(y)dy/y2,
we obtain
f = ωχ′(x)/x3 − 3ωχ(x)/x4 + (λ+ µ0)χ(x)/x3 − β
∫ ∞
x
χ′(y)dy/y2.
Obviously, f as well as xf belong to L1(R+), so A−B with domain D(A) is not closed.
2.7. Summary. Let us summarize what we have shown so far.
Theorem 2.3. Suppose βω ≤ µ20. Then problem (2.2) is well-posed in X = L1(R+; (a+x)dx) and
admits an associated C0-semigroup T (t) = e
−Lt which is positive. If a is chosen from the interval
a ∈ [ω/µ0, µ0/β] then T (t) is nonexpansive.
In the strictly disease free case ω = λτ/γ < µ20/β, the semigroup T (t) is exponentially stable
with type ω0(T ) ≤ −µ0 +
√
λβτ/γ < 0.
3. Asymptotic Behavior of the Autonomous Problem
3.1. Compactness. Set L = A−B. Since L is m-accretive in X = L1(R+; (a + x)dx), the
spectrum σ(L) is contained in the closed right halfplane. We want to show that the resolvent of L
is compact. For this purpose we derive another representation of (λ+ L)−1 for λ > 0. Let f ∈ X
and set u = (λ+ L)−1f . Then we obtain
u = (λ+A)−1f + (λ +A)−1Bu,
and
(λ +A)−1Bu = 2β(λ +A)−1[
∫ ∞
x
u(y)dy]
=
2β
ω
∫ x
0
e−(λ+µ0)(x−y)/ωe−β(x
2−y2)/2ω[
∫ ∞
y
u(r)dr]dy
=
2β
ω
∫ ∞
x
u(r)[
∫ x
0
e−(λ+µ0)(x−y)/ωe−β(x
2−y2)/2ωdy]dr
+
2β
ω
∫ x
0
u(r)[
∫ r
0
e−(λ+µ0)(x−y)/ωe−β(x
2−y2)/2ωdy]dr
= kλ(x)
∫ ∞
x
u(r)dr + ω(λ+A)−1[kλu],
where
kλ(x) =
2β
ω
∫ x
0
e−(λ+µ0)(x−y)/ωe−β(x
2−y2)/2ωdy.
Note that
0 ≤ kλ(x) ≤ 2β
ω
∫ x
0
e−(λ+µ0)(x−y)/ωdy ≤ 2β
λ+ µ0
,
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i.e. kλ ∈ L∞(R+). We thus have the identity
u(x)− kλ(x)
∫ ∞
x
u(y)dy = (λ+A)−1f(x) + ω(λ+A)−1[kλu] =: g(x),
and u(0) = 0. We may solve this equation for u to the result
u(x) = g(x)− kλ(x)
∫ x
0
exp
(
−
∫ x
y
kλ(r)dr
)
g(y)dy + kλ(x) exp
(
−
∫ x
0
kλ(s)ds
)
< qλ|f >,
where
< qλ, f >:=
1
(λ+ µ0)2 − ωβ ((λ + µ0)
∫ ∞
0
f(s)ds+ β
∫ ∞
0
sf(s)ds) .
This way we have the representation
(3.1) (λ+L)−1f = (1−Rλ)(λ+A)−1[1+ωkλ(λ+L)−1]f +kλ(x) exp
(
−
∫ x
0
kλ(s)ds
)
< qλ|f >,
with
(Rλg)(x) = kλ(x)
∫ x
0
exp
(
−
∫ x
y
kλ(r)dr
)
g(y)dy.
Next D(A) embeds compactly into X , hence (λ + A)−1 is compact. From boundedness of kλ we
may then conclude that (λ+ L)−1 is compact, as soon as we know that the Volterra operator Rλ
is bounded in X .
To prove the latter we estimate as follows
||Rλg|| =
∫ ∞
0
(a+ x)kλ(x)|
∫ x
0
exp
(
−
∫ x
y
kλ(r)dr
)
g(y)dy|dx
≤
∫ ∞
0
|g(y)|[
∫ ∞
y
(a+ x)kλ(x) exp
(
−
∫ x
y
kλ(r)dr
)
dx]dy
=
∫ ∞
0
|g(y)|[(a+ y) +
∫ ∞
y
exp
(
−
∫ x
y
kλ(r)dr
)
dx]dy
≤ Cλ
∫ ∞
0
|g(y)|(a+ y)dy = Cλ||g||,
as we show now.
kλ(x) =
2β
ω
∫ x
0
e−(λ+µ0)(x−y)/ωe−β(x
2−y2)/2ωdy
≥ 2β
ω
∫ x
0
e−(λ+µ0)y/ωe−βxy/ωdy
=
2β
λ+ µ0 + βx
(1− e−(λ+µ0+βx)x/ω)
≥ 2β
λ+ µ0 + βx
· (λ+ µ0 + βx)x/ω
1 + (λ+ µ0 + βx)x/ω)
=
2βx
ω + (λ + µ+ βx)x
,
by the elementary inequality 1− e−x ≥ x/(1 + x). This implies∫ x
y
kλ(r)dr ≥ 2β
∫ x
y
rdr/(ω + (λ+ µ0 + βr)r
=
∫ x
y
2βr + λ+ µ0
ω + (λ+ µ0)r + βr2
dr − (λ + µ0)
∫ x
y
dr
ω + (λ+ µ0)r + βr2
≥ log ω + (λ+ µ0)x + βx
2
ω + (λ+ µ0)y + βy2
− cλ,
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since the second integral is bounded. This estimate finally yields∫ ∞
y
exp
(
−
∫ x
y
kλ(r)dr
)
dx ≤ ecλ
∫ ∞
y
ω + (λ+ µ0)y + βy
2
ω + (λ + µ0)x+ βx2
dx ≤ Cλ(a+ y).
This completes the proof of compactness of the resolvent of L.
3.2. Ergodicity. Since the resolvent of L is compact we know that the spectrum of L consists
only of eigenvalues of finite multiplicity, these are poles of the resolvent of L. By accretivity of
L we have the inequality |(λ + L)−1|B(X) ≤ 1/Reλ, Reλ > 0, hence the resolvent can only have
poles of first order on the imaginary axis. This shows that all eigenvalues on the imaginary axis
are semisimple. Compactness of the resolvent implies also that the range of λ + L is closed, for
each λ ∈ C. In particular, we have the direct sum decomposition X = N(L)⊕R(L), i.e. ergodicity
in the sense of Abel.
Now we concentrate on the disease equilibrium which means a = µ0/β and ω = µ
2
0/β. A
function e(x) belongs to the kernel of L if
ωe′(x) + (µ0 + βx)e(x) − 2β
∫ ∞
x
e(y)dy = 0, x > 0, e(0) = 0,
or equivalently
e′′(x) +
β
µ0
(1 +
β
µ0
x)e′(x) + 3
β2
µ20
e(x) = 0, x > 0, e(0) = 0.
The scaling e(x) = v(βx/µ0) reduces this problem to
v′′(z) + (1 + z)v′(z) + 3v(z) = 0, z > 0, v(0) = 0.
By the initial condition v(0) = 0, this shows that the kernel of L can be only one-dimensional, and
a simple computation yields that
v(z) = (z + z2/2)e−(z+z
2/2), z > 0,
is a solution. Therefore N(L) = span{e}, with e(x) = (β/µ0)2v(βx/µ0), and another simple
computation yields ∫ ∞
0
(a+ x)e(x)dx = 1.
Since L is Fredholm with index zero, the kernel N(L∗) of the dual of L has also a one-dimensional
kernel which are the constant functions. The ergodic projection P onto the kernel of L along the
range of L is then given by
(3.2) Pu(x) = [
∫ ∞
0
(a+ x)u(x)dx]e(x) =< u|e∗ > e(x), x > 0.
Suppose there are no other eigenvalues of L on the imaginary axis. Then L∗ also has no other
eigenvalues on the imaginary axis, and then by the theorem of Arendt, Batty, Lubich and Phong
we may conclude that
e−Ltu→ Pu as t→∞, for each u ∈ X,
i.e. the semigroup generated by −L is strongly ergodic.
We show now that there are in fact no eigenvalues other than 0 on the imaginary axis. Suppose
on the contrary that
iρu(x) + ωu′(x) + (µ0 + βx)u(x) = 2β
∫ ∞
x
u(y)dy, x > 0, u(0) = 0,
u 6= 0. Multiplying this equation with u¯/|u|, taking real parts, and integrating over R+ we obtain
(3.3) µ0|u|1 + β|xu|1 = 2βRe
∫ ∞
0
u(x)
∫ x
0
u¯(y)/|u(y)|dydx ≤ 2β|xu|1,
and similarly, multiplying with xu¯(x)/|u(x)| we get
(3.4) −ω|u|1 + µ0|xu|1 + β|x2u|1 = 2βRe
∫ ∞
0
u(x)
∫ x
0
yu¯(y)/|u(y)|dydx ≤ β|x2u|1.
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Multiplying the first inequality with a = µ0/β and adding the second we arrive at a contradiction
if at least one of the inequalities (3.3), (3.4) is strict. Hence we must have
Re
∫ ∞
0
u(x)
∫ x
0
u¯(y)/|u(y)|dydx = |xu|1,
which implies with arg u(x) = θ(x)
x ≡ Re
∫ x
0
ei(θ(x)−θ(y))dy =
1
2
d
dx
|
∫ x
0
eiθ(y)dy|2,
or equivalently
|
∫ x
0
eiθ(y)dy|2 = x2, x > 0.
But this is only possible if θ(y) is constant, w.l.o.g. we may assume θ = 0 i.e. u(x) is nonnegative,
which in turn yields ρ = 0 since u 6= 0 by assumption.
3.3. Summary. Let us summarize what we have shown in this section.
Theorem 3.1. Assume the disease case ω = µ20/β, a = µ0/β. The the semigroup T (t) = e
−Lt
is strongly ergodic, it converges strongly to the projection P onto the kernel N(L) of L along
its range R(L). The kernel is one-dimensional and spanned by e(x) = (β/µ0)
2Φ(βx/µ0), where
Φ(z) = (z + z2/2)e−(z+z
2/2), and the projection P is given by
Pu(x) = [
∫ ∞
0
(a+ y)u(y)dy]e(x) =< e∗|u > e(x), x > 0, u ∈ X.
Remark. We do not know whether the ergodicity is exponential since it is not clear that the
type of the semigroup e−Lt restricted to R(L) is negative.
4. Well-posedness of the Non-Autonomous Evolution
4.1. The Trivial Evolution. Let ω ∈ C(R+) be positive, such that 0 < ω∞ = limt→∞ ω(t)
exists, and assume ω(·)− ω∞ ∈ L1(R+). Let
ω+ = max
s≥0
ω(s) and ω− = min
s≥0
ω(s),
and note that ω+ ≥ ω− > 0. We are particularly interested in the cases ω∞ = λτ/γ, the disease-
free case, and ω∞ = µ
2
0/β, the disease case. We want to show that the nonautonomous problem is
well-posed in X = L1(R+; (a+ x)dx). We begin with the problem
∂tu(t, x) + ω(t)∂xu(t, x) + (µ0 + βx)u(t, x) = 0, x > 0, t > s ≥ 0(4.1)
u(s, x) = g(x), u(t, 0) = 0, t > s ≥ 0, x > 0.
The method of characteristics yields easily the evolution operator U0(t, s) for this problem. It is
given by
[U0(t, s)g](x) = u(t, x) = g(x−
∫ t
s
ω(τ)dτ)e−φ(t,s,x),(4.2)
φ(t, s, x) = µ0(t− s) + β(t− s)(x −
∫ t
s
ω(τ)dτ) + β
∫ t
s
(t− τ)ω(τ)dτ,
if we extend g trivially to R. We obviously have the estimate |U0(t, s)|B(X) ≤ e−µ0(t−s), and u(t, x)
is a strong solution in X if the initial function g belongs to D defined by
D := {g ∈ L1(R+) : x2g, g′, xg′ ∈ L1(R+), g(0) = 0}.
We also need the solution of
∂tu(t, x) + ω(t)∂xu(t, x) + (µ0 + βx)u(t, x) = 0, x > 0, t > s ≥ 0
u(s, x) = 0, u(t, 0) = h(t), t > s ≥ 0, x > 0.(4.3)
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Again the method of characteristics applies and yields with K(t, x) =
∫ t
ρ(t,x)
(r− ρ(t, x))ω(r)dr the
formula
[V0(t, s)h](x) = u(t, x) = h(ρ(t, x))e
−[µ0(t−ρ(t,x)+βx(t−ρ(t,x))−βK(t,x)],
for x <
∫ t
s
ω(r)dr, and zero elsewhere, where the function ρ(t, x) is defined by the equation
(4.4) x =
∫ t
ρ
ω(r)dr;
note that this equation has a unique solution ρ(t, x) ∈ (s, t), since ω(r) ≥ ω− > 0 for all r ≥ 0, by
assumption, and x <
∫ t
s
ω(r)dr. Observe that with K0(t, s) =
∫ t
s
ω(r)dr we have
∫ ∞
0
(a+ x)[V0(t, s)h](x)dx ≤ |h|∞
∫ K0(t,s)
0
(a+ x)e−µ0(t−ρ(t,x))dx
≤ |h|∞
∫ t
s
(a+
∫ t
σ
ω(r)dr)e−µ0(t−σ)ω(ρ(t, x))dσ
≤ |h|∞ω+
∫ t−s
0
(a+ ω+σ)e
−µ0σdσ ≤ C|h|∞,
by the variable transformation σ = ρ(t, x). Thus the part coming from a nontrivial bounded
boundary value h is bounded in X .
4.2. Well-posedness for the Full Problem. Let us now consider the full problem, i.e.
∂tu(t, x) + ω(t)∂xu(t, x) + (µ0 + βx)u(t, x) = 2β
∫ ∞
x
u(t, y)dy,(4.5)
u(s, x) = g(x), u(t, 0) = 0, t > s ≥ 0, x > 0.
Since the standard cone in X is reproducing, i.e. L1 = L
+
1 − L+1 , we may restrict attention to
nonnegative initial functions g. We define the sequence un inductively by
u1(t) := U0(t, s)g, un+1(t) = u1(t) +
∫ t
s
U0(t, r)Bun(r)dr, t ≥ s ≥ 0.
Since U0(t, s) is positive the functions un are as well, and u2(t) ≥ u1(t) since B is positive.
Inductively we obtain with
un+1(t)− un(t) =
∫ t
s
U0(t, r)B(un(r) − un−1(r))dr, t ≥ s ≥ 0,
that the functions un are pointwise increasing w.r.t. n ∈ N.
Suppose that g ∈ D. Then un is a strong solution of
∂tun(t, x) + ω(t)∂xun(t, x) + (µ0 + βx)un(t, x) = 2β
∫ ∞
x
un−1(t, y)dy
≤ 2β
∫ ∞
x
un(t, y)dy, x > 0, t > s ≥ 0
u(s, x) = g(x), u(t, 0) = 0, t > s ≥ 0, x > 0,
i.e. un is a strong lower solution of (4.5). Multiplying the equation with x
i and integrating over
R+ this yields with zi(t) = |xiun(t)|1
∂tz0(t) + µ0z0(t) + βz1(t) ≤ 2βz1(t),
for i = 0, and for i = 1
∂tz1(t)− ω(t)z0(t) + µ0z1(t) + βz2(t) ≤ βz2(t).
Setting z(t) = (z0(t), z1(t))
T , b(t) = (0, (ω(t) − ω∞)z0(t))T , and defining G by the 2 × 2-matrix
with entries −µ0, β, ω∞,−µ0, this inequality becomes
∂tz(t) ≤ Gz(t) + b(t), t ≥ s ≥ 0.
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The eigenvalues of G are given by λ± = −µ0 ±
√
βω∞ which are both nonpositive if βω∞ ≤ µ20,
which is true in both, the disease-free and the disease case. Since eGt is positive we may conclude
z(t) ≤ eG(t−s)z(s) +
∫ t
s
eG(t−r)b(r)dr.
Boundedness of eGt then implies an inequality of the form
|z(t)| ≤ C + C
∫ t
s
|ω(r)− ω∞||z(r)|dr, t ≥ s ≥ 0,
which implies boundedness of z(t) on [s,∞) since (ω(·)−ω∞) ∈ L1(R+) by assumption. Note that
the constant C depends only on the parameters µ0, β, ω∞ and on ||g||.
Therefore the functions un(t) are bounded in X uniformly in t and n. By monotone convergence
we may conclude un(t) → u(t) in X for each t ≥ s. Since B is positive, Bun → Bu in L1(R+) as
well, and then also
(4.6) u(t) = U0(t, s)g +
∫ t
s
U0(t, r)Bu(r)dr, t ≥ s ≥ 0,
at least in L1(R+). A density argument finally shows that this conclusion is valid for all initial
data g ∈ X .
Remark. It is not clear that solutions of (4.6) are unique. The reason for this is that B is
unbounded. Therefore we need another definition of mild solution.
Definition.Let f ∈ L1,loc(R+;X).
(i) We call a function u ∈ C(R+;X) strong solution of
∂tu(t, x) + ω(t)∂xu(t, x) + (µ0 + βx)u(t, x) = 2β
∫ ∞
x
u(t, y)dy + f(t, x),
u(s, x) = g(x), u(t, 0) = 0, t > s ≥ 0, x > 0.(4.7)
if u ∈ C1(R+;X) ∩ C(R+;D) and (4.7) is valid pointwise.
(ii) We call a function u ∈ C(R+;X) mild solution of (4.7) if there are fn ∈ L1,loc(R+;X) and
strong solutions un of (4.7) such that un → u and fn → f as n→∞, in X, uniformly on compact
intervals.
Suppose that g ∈ D has compact support. Then each iteration un(t) has also compact support,
namely
suppun(t) ⊂ supp g + ω+[0, t],
for each n ∈ N. Therefore each function un(t) is a strong solution of (4.7) with inhomogeneity
fn(t) = B(un−1(t)−un(t)). This proves that the limit u(t) is a mild solution. Approximation then
shows that (4.5) has at least one mild solution, for each initial value g ∈ X .
Uniqueness of mild solutions can be obtained as follows. If u is a strong solution of (4.7) then
the equation yields as above the inequality
∂t||u(t)|| ≤ ω+||u(t)||+ ||f(t)||, t > 0,
hence
||u(t)|| ≤ eω+(t−s)||g||+
∫ t
s
eω+(t−r)||f(r)||dr.
By approximation this inequality is also valid for mild solutions, hence u ≡ 0 in case f ≡ g = 0.
Thus mild solutions are unique and of course they satisfy the integral equation (4.6).
4.3. Summary. We have proved the following result about well-posedness of (4.5)
Theorem 4.1. Suppose ω ∈ C(R+) is a given strictly positive function, such that ω∞ =
limt→∞ ω(t) > 0 exists and ω(·) − ω∞ ∈ L1(R+). Then (4.5) is well-posed in the sense of the
definition given above. There exists a unique evolution operator U(t, s) in X generated by (4.5),
which is bounded in X, uniformly in 0 ≤ s ≤ t <∞, and positive. Moreover, (4.5) has finite speed
of propagation with maximum speed less than ω+ = supt≥0 ω(t).
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4.4. Higher Order Bounds. Consider an initial function g ∈ C∞0 (0,∞). Then u1 is smooth as
well and has compact support for each t ≥ s. Then the same holds true for u2, hence by induction
for all un. Setting vn = ∂xun we have the following problem for vn.
∂tvn + ω(t)∂xvn + (µ0 + βx)vn = −β[un + 2un−1],(4.8)
vn(s, x) = g
′(x), vn(t, 0) = ψn(t), t > s ≥ 0, x > 0
where ψn(t) =
2β
ω(t) |un−1(t)|1. This implies
∂xun(t) = vn(t) = U0(t, s)g
′ − β
∫ t
s
U0(t, r)[un(r) + 2un−1(r)]dr + wn(t), t ≥ s ≥ 0,
with
wn(t) = 2βV0(t, s)[|un−1(·)|1/ω(·)].
Uniform boundedness of un in X and exponential stability of the evolution operator U0(t, s) in X
then implies boundedness of ∂xun in X . Passing to the limit we get
∂xu(t) = U0(t, s)g
′ − 3β
∫ t
s
U0(t, r)u(r)dr + w(t), t ≥ s ≥ 0,
where
w(t, x) = 2βV0(t, s)[|u(·)|1/ω(·)].
This yields ∂xu ∈ Cb([s,∞);X). The last identity was proven for g ∈ C∞0 (0,∞), but via density
can be extended to g ∈ D.
5. Convergence
We are now ready to prove the main result on convergence. Let us first look at the disease-
free case. Then with A(t), B, defined as in section 2, and L(t) = A(t)−B, we know that L(t)
is strictly accretive for large times t if the parameter a is chosen in a ∈ (λτ/γµ0, µ0/β). This
proves exponential stability of the trivial solution in the disease-free case, with decay rate at least
µ0 −
√
λβτ/γ.
Suppose we have a solution u of the nonautonomous problem in the disease case such that ∂xu(t)
is bounded in X . Then we may write
∂tu+ ω∞∂xu+ (µ0 + βx)u − 2β
∫ ∞
x
u(t, y)dy = (ω∞ − ω(t))∂xu,(5.1)
u(0, x) = g(x), u(t, 0) = 0, t > 0, x > 0.
Therefore we obtain the identity
u(t) = e−Ltg +
∫ t
0
e−L(t−r)(ω∞ − ω(r))∂xu(r))dr, t ≥ 0.
We know from Section 9 that e−Lt converges strongly in X to the ergodic projection P . On the
other hand, the scalar function ω(·)− ω∞ belongs to L1(R+) by assumption. This then implies
u(t)→ u∞ ∈ R(P).
Thus we have convergence in X to a unique element for all nonnegative solutions with initial values
in D. Since the evolution operator associated with (4.5) is bounded in X , this convergence extends
to all initial values u0 ∈ X .
Returning now to the system (1.1), we may compute the limit u∞. For this purpose recall that
U(t) =
∫∞
x0
u(t, x)dx→ U∞ and P (t) =
∫∞
x0
u(t, x)xdx→ P∞. This implies
u∞ = lim
t→∞
Pu(t) = lim
t→∞
[aU(t) + P (t)− x0U(t)]e = [µU∞/β + P∞]e.
Note that u∞ is independent of the initial values V0 and u0.
This completes the proof of Theorem 1.2.
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